Outcomes of controlled human malaria infection after BCG vaccination
Jona Walk, L. Charlotte J. de Bree, Wouter Graumans et al. · Nature Communications · 2019 · Randomised trial
Full textCC BY
Immunology
Filters3 filters applied
Status
Year
Study type
Licence
Corrected Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
Pirow Bekker, Daniel Dairaghi, Lisa Seitz et al. · PLOS ONE · 2016 · Randomised trial
Full textCC BY
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
Vasso Apostolopoulos, Geoffrey A Pietersz, Anastasios Tsibanis et al. · Breast Cancer Research · 2006 · Randomised trial
Full textCC BY